FCMI
SNDX icon

Foresite Capital Management IV’s Syndax Pharmaceuticals SNDX Stock Holding History

Foresite Capital Management IV’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-875,000
Closed -$16.8M – 5
2024
Q3 		$16.8M Hold
875,000
– – 11.01% 3
2024
Q2 		$18M Hold
875,000
– – 12.07% 3
2024
Q1 		$20.8M Hold
875,000
– – 10.52% 4
2023
Q4 		$18.9M Hold
875,000
– – 9.56% 4
2023
Q3 		$12.7M Hold
875,000
– – 7.06% 7
2023
Q2 		$18.3M Hold
875,000
– – 9% 7
2023
Q1 		$18.5M Hold
875,000
– – 9.59% 6
2022
Q4 		$22.3M Buy
875,000
+185,000
+27% +$4.31M 9.51% 6
2022
Q3 		$16.6M Buy
+690,000
New +$15.5M 5.33% 6

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return